John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 200 shares at $27.00 ($5K) on 2025-05-07, disclosed to the SEC on 2025-05-09.
Scheduled sale ($5k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2024-09-04 | $3.1M | — | Filing → |